Introduction: Dental caries remains a prevalent oral health issue worldwide, with Lactobacillus acidophilus playing a significant role in its progression. While traditional antimicrobial agents like chlorhexidine are effective, the increasing concern of antimicrobial resistance has spurred interest in alternative approaches. Dielectric barrier discharge (DBD) plasma, a form of cold atmospheric plasma (CAP), has shown promise in various biomedical applications, including dentistry. This in vitro study aims to determine the effect of DBD plasma radiation on the amount of L. acidophilus bacteria. Methods:Lactobacillus acidophilus (ATCC 43121) cultures were subjected to DBD plasma treatment for 30, 90, 120, and 150 seconds. A positive control group was treated with 2% chlorhexidine, and a negative control received no treatment. Bacterial viability was assessed using colony-forming unit (CFU) counts. One-way ANOVA and Tukey's HSD test were used for statistical analysis. P values less than 0.05 were considered significant. Results: The 30-second DBD plasma treatment significantly reduced L. acidophilus populations compared to the negative control (32.9% reduction, P<0.001). However, longer exposure times (90, 120, and 150 seconds) showed diminished antibacterial effects. The 2% chlorhexidine treatment demonstrated the highest antibacterial efficacy (54.8% reduction, P<0.001 compared to all other groups). Conclusion: It seems that short-duration DBD plasma treatment (30 seconds) effectively reduced L. acidophilus populations, although not as efficiently as chlorhexidine. Interestingly, prolonged plasma exposure did not enhance antibacterial effects, suggesting a potential adaptive response of bacteria to extended plasma treatment. These findings highlight the promise of DBD plasma as a novel approach to dental caries prevention while emphasizing the need for optimized treatment parameters.
{"title":"The Effect of Dielectric Barrier Discharge Plasma on <i>Lactobacillus acidophilus</i>: An In Vitro Study.","authors":"Ghazaleh Shahhosseini, Somayeh Alirezaei, Arezoo Alaee, Mahsa Fattahi","doi":"10.34172/jlms.2025.23","DOIUrl":"10.34172/jlms.2025.23","url":null,"abstract":"<p><p><b>Introduction:</b> Dental caries remains a prevalent oral health issue worldwide, with <i>Lactobacillus acidophilus</i> playing a significant role in its progression. While traditional antimicrobial agents like chlorhexidine are effective, the increasing concern of antimicrobial resistance has spurred interest in alternative approaches. Dielectric barrier discharge (DBD) plasma, a form of cold atmospheric plasma (CAP), has shown promise in various biomedical applications, including dentistry. This in vitro study aims to determine the effect of DBD plasma radiation on the amount of <i>L. acidophilus</i> bacteria. <b>Methods:</b> <i>Lactobacillus acidophilus</i> (ATCC 43121) cultures were subjected to DBD plasma treatment for 30, 90, 120, and 150 seconds. A positive control group was treated with 2% chlorhexidine, and a negative control received no treatment. Bacterial viability was assessed using colony-forming unit (CFU) counts. One-way ANOVA and Tukey's HSD test were used for statistical analysis. <i>P</i> values less than 0.05 were considered significant. <b>Results:</b> The 30-second DBD plasma treatment significantly reduced <i>L. acidophilus</i> populations compared to the negative control (32.9% reduction, <i>P</i><0.001). However, longer exposure times (90, 120, and 150 seconds) showed diminished antibacterial effects. The 2% chlorhexidine treatment demonstrated the highest antibacterial efficacy (54.8% reduction, <i>P</i><0.001 compared to all other groups). <b>Conclusion:</b> It seems that short-duration DBD plasma treatment (30 seconds) effectively reduced <i>L. acidophilus</i> populations, although not as efficiently as chlorhexidine. Interestingly, prolonged plasma exposure did not enhance antibacterial effects, suggesting a potential adaptive response of bacteria to extended plasma treatment. These findings highlight the promise of DBD plasma as a novel approach to dental caries prevention while emphasizing the need for optimized treatment parameters.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e23"},"PeriodicalIF":1.5,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12534763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-02eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.21
Reza M Robati, Hamideh Moravvej Farshi, Babak Arjmand, Zahra Razzaghi, Mitra Rezaei, Fatemeh Bandarian, Farideh Razi, Vahid Mansouri, Mostafa Rezaei-Tavirani
Introduction: Sunscreen plays an unexpected role in protecting the skin against the harmful effects of sunlight. Skin protection against UV rays is highlighted as the main property of sunscreen. The present study investigated the core part of the molecular mechanism of skin protection by sunscreen. Methods: Gene expression changes of the irradiated human skin with sunlight in the presence of sunscreen were mined from the Gene Expression Omnibus (GEO) database and analyzed to find the significantly differentially expressed genes (DEGs). The central DEGs were identified via the protein-protein interaction (PPI) network and searched in skin cancer-related genes in the GeneCards database to find the critical dysregulated genes. The gene expression change of the critical genes was investigated in the Cancer Genome Atlas (TCGA) database. Results: A total of 377 DEGs were determined as the targeted genes. HSPA4, PTEN, CDC42, ERBB2, APP, CDKN2A, PRKACA, PECAM1, and SMAD3 were identified as the critical dysregulated genes. ERBB2, SMAD3, and PRKACA were pointed out as the skin cancer-related genes. Conclusion: In conclusion, the up-regulation of PETN and the activation of CDKN2A were highlighted as the major induced molecular events by sunscreen, which play a role in skin protection.
{"title":"Activation of CDKN2A and Up-regulation of PETN Are Key Features of Sunscreen Usage Versus Light Irradiation.","authors":"Reza M Robati, Hamideh Moravvej Farshi, Babak Arjmand, Zahra Razzaghi, Mitra Rezaei, Fatemeh Bandarian, Farideh Razi, Vahid Mansouri, Mostafa Rezaei-Tavirani","doi":"10.34172/jlms.2025.21","DOIUrl":"10.34172/jlms.2025.21","url":null,"abstract":"<p><p><b>Introduction:</b> Sunscreen plays an unexpected role in protecting the skin against the harmful effects of sunlight. Skin protection against UV rays is highlighted as the main property of sunscreen. The present study investigated the core part of the molecular mechanism of skin protection by sunscreen. <b>Methods:</b> Gene expression changes of the irradiated human skin with sunlight in the presence of sunscreen were mined from the Gene Expression Omnibus (GEO) database and analyzed to find the significantly differentially expressed genes (DEGs). The central DEGs were identified via the protein-protein interaction (PPI) network and searched in skin cancer-related genes in the GeneCards database to find the critical dysregulated genes. The gene expression change of the critical genes was investigated in the Cancer Genome Atlas (TCGA) database. <b>Results:</b> A total of 377 DEGs were determined as the targeted genes. HSPA4, PTEN, CDC42, ERBB2, APP, CDKN2A, PRKACA, PECAM1, and SMAD3 were identified as the critical dysregulated genes. ERBB2, SMAD3, and PRKACA were pointed out as the skin cancer-related genes. <b>Conclusion:</b> In conclusion, the up-regulation of PETN and the activation of CDKN2A were highlighted as the major induced molecular events by sunscreen, which play a role in skin protection.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e21"},"PeriodicalIF":1.5,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12534772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-14eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.20
Mostafa Rezaei-Tavirani, Babak Arjmand, Zahra Razzaghi, Reza M Robati
Introduction: Blue light with therapeutic properties is the high-energy part of the visible light spectrum with various biological effects. The main aim of this study is to elucidate blue light exposure and anxiety via protein-protein interaction (PPI) network analysis. Methods: Anxiety-related genes were extracted from the GeneCards database and assessed via gene clustering and PPI network analysis to identify the hub genes. Blue light-targeted genes in 3D skin were revealed from the Gene Expression Omnibus (GEO) database, and the significant differentially expressed genes (DEGs) were identified. The significant DEGs were searched among the hub genes. The common significant DEGs and the hub genes, together with their first neighbors, were determined and discussed. Results: A total number of 56 significant DEGs were pointed out as the targets of blue light. Among the 10696 anxiety-related genes, 772 individuals were selected as top genes and evaluated via PPI network analysis. IL6 appeared as the common gene between the significant DEGs and the 55 hub genes of the PPI network. Twelve genes were pointed out as the first neighbors of IL6. GIFtS analysis showed that Il6, H3-5, PFN1, DEFB103A, HMGB1, and RPLP1 were genes related to anxiety and were targeted by blue light. Conclusion: In conclusion, six targeted genes by blue light were related to anxiety. Downregulation of IL6 appeared as a factor in improving anxiety. However, the first neighbors of IL6 were not consistent with the role of IL6 in the decrement of anxiety.
导读:蓝光是可见光光谱中具有治疗作用的高能部分,具有多种生物效应。本研究的主要目的是通过蛋白质-蛋白质相互作用(PPI)网络分析来阐明蓝光暴露与焦虑之间的关系。方法:从GeneCards数据库中提取焦虑相关基因,通过基因聚类和PPI网络分析进行评估,确定中心基因。从Gene Expression Omnibus (GEO)数据库中发现3D皮肤中的蓝光靶向基因,并鉴定出显著差异表达基因(DEGs)。在中心基因中寻找显著的deg。确定并讨论了共同显著deg和枢纽基因,以及它们的第一个邻居。结果:共发现56个显著的deg为蓝光的靶蛋白。在10696个焦虑相关基因中,选取772个个体作为top基因,通过PPI网络分析对其进行评价。il - 6是显著deg与PPI网络55个枢纽基因之间的共同基因。12个基因被认为是IL6的第一个邻居。gift分析显示,Il6、H3-5、PFN1、DEFB103A、HMGB1和RPLP1是与焦虑相关的基因,是蓝光靶向的基因。结论:6个蓝光靶向基因与焦虑相关。il - 6的下调似乎是改善焦虑的一个因素。然而,IL6的第一个邻居与IL6在减轻焦虑中的作用并不一致。
{"title":"Assessment of the Connection Between Blue Light and Anxiety: A System Biology Approach.","authors":"Mostafa Rezaei-Tavirani, Babak Arjmand, Zahra Razzaghi, Reza M Robati","doi":"10.34172/jlms.2025.20","DOIUrl":"10.34172/jlms.2025.20","url":null,"abstract":"<p><p><b>Introduction:</b> Blue light with therapeutic properties is the high-energy part of the visible light spectrum with various biological effects. The main aim of this study is to elucidate blue light exposure and anxiety via protein-protein interaction (PPI) network analysis. <b>Methods:</b> Anxiety-related genes were extracted from the GeneCards database and assessed via gene clustering and PPI network analysis to identify the hub genes. Blue light-targeted genes in 3D skin were revealed from the Gene Expression Omnibus (GEO) database, and the significant differentially expressed genes (DEGs) were identified. The significant DEGs were searched among the hub genes. The common significant DEGs and the hub genes, together with their first neighbors, were determined and discussed. <b>Results:</b> A total number of 56 significant DEGs were pointed out as the targets of blue light. Among the 10696 anxiety-related genes, 772 individuals were selected as top genes and evaluated via PPI network analysis. IL6 appeared as the common gene between the significant DEGs and the 55 hub genes of the PPI network. Twelve genes were pointed out as the first neighbors of IL6. GIFtS analysis showed that Il6, H3-5, PFN1, DEFB103A, HMGB1, and RPLP1 were genes related to anxiety and were targeted by blue light. <b>Conclusion:</b> In conclusion, six targeted genes by blue light were related to anxiety. Downregulation of IL6 appeared as a factor in improving anxiety. However, the first neighbors of IL6 were not consistent with the role of IL6 in the decrement of anxiety.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e20"},"PeriodicalIF":1.5,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12534765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-13eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.19
Samer Al-Rawashdah, Malik Ayyad, Omar Ayaad, Khalil Abu Zahra, Saddam Al Demour, Mohammad Al-Zubi
Introduction: Holmium laser prostatectomy (HoLEP) is widely used for benign prostatic hyperplasia (BPH), though primary bladder neck obstruction (PBNO) is less commonly recognized despite similar symptoms. Treatment outcomes can vary, especially when diagnosis is delayed, but the condition is sometimes not very different from BPH. The purpose of this study was to compare PBNO patients with those undergoing surgery for BPH, even though PBNO is not always treated surgically. Methods: A total of 79 men from three hospitals in Jordan (PBNO=30, BPH=49) were reviewed retrospectively. They all received HoLEP regardless of individual suitability or prior diagnostic clarity. Data were collected through symptom scoring (IPSS, OABSS), but not all patients completed the follow-ups equally. Results: While patients with PBNO showed symptom improvement after surgery, the improvements were not always significant or clearly linked to the procedure itself. Interestingly, PBNO patients had shorter surgeries (27.2 vs. 60.5 minutes, P<0.01), though it is unclear whether that impacted recovery. Despite reporting fewer complications, their satisfaction was lower (64.3% vs. 93.8%, P=0.09), perhaps due to reasons not directly assessed in the study. Repeated Measures ANOVA revealed a statistically significant improvement in IPSS scores over time in both groups: PBNO (F(2.1, 58.4)=16.8, P<0.001) and BPH (F(2.4, 116.8)=21.3, P<0.001). Similarly, OABSS scores showed a significant improvement over time for both PBNO (F(2.6, 74.0)=8.9, P<0.001) and BPH (F(2.8, 134.2)=9.7, P<0.001). Conclusion: HoLEP appears effective for PBNO, though it may not be the most suitable approach in all cases. Since PBNO differs from BPH, further studies might be needed, or perhaps not, depending on patient variability.
钬激光前列腺切除术(HoLEP)被广泛应用于良性前列腺增生(BPH),尽管原发性膀胱颈梗阻(PBNO)的症状相似,但却不太常见。治疗结果可能不同,特别是当诊断延迟时,但情况有时与BPH没有太大区别。本研究的目的是比较PBNO患者与接受BPH手术的患者,尽管PBNO并不总是通过手术治疗。方法:回顾性分析来自约旦3家医院的79例男性患者(PBNO=30, BPH=49)。他们都接受了HoLEP治疗,无论个人是否适合或先前的诊断是否明确。通过症状评分(IPSS, OABSS)收集数据,但并非所有患者都完成了随访。结果:虽然PBNO患者在手术后表现出症状改善,但这种改善并不总是显著或与手术本身明确相关。有趣的是,PBNO患者的手术时间较短(27.2 vs. 60.5分钟,PP=0.09),可能是由于研究中没有直接评估的原因。重复测量方差分析显示,随着时间的推移,两组患者的IPSS评分均有统计学意义上的改善:PBNO (F(2.1, 58.4)=16.8, ppppp。结论:HoLEP对PBNO似乎有效,尽管它可能不是最适合所有病例的方法。由于PBNO不同于BPH,可能需要进一步的研究,也可能不需要,这取决于患者的可变性。
{"title":"Holmium Laser Prostatectomy for Primary Bladder Neck Obstruction (PBNO): Comparative Efficacy and Safety Outcomes versus Benign Prostatic Hyperplasia (BPH).","authors":"Samer Al-Rawashdah, Malik Ayyad, Omar Ayaad, Khalil Abu Zahra, Saddam Al Demour, Mohammad Al-Zubi","doi":"10.34172/jlms.2025.19","DOIUrl":"10.34172/jlms.2025.19","url":null,"abstract":"<p><p><b>Introduction:</b> Holmium laser prostatectomy (HoLEP) is widely used for benign prostatic hyperplasia (BPH), though primary bladder neck obstruction (PBNO) is less commonly recognized despite similar symptoms. Treatment outcomes can vary, especially when diagnosis is delayed, but the condition is sometimes not very different from BPH. The purpose of this study was to compare PBNO patients with those undergoing surgery for BPH, even though PBNO is not always treated surgically. <b>Methods:</b> A total of 79 men from three hospitals in Jordan (PBNO=30, BPH=49) were reviewed retrospectively. They all received HoLEP regardless of individual suitability or prior diagnostic clarity. Data were collected through symptom scoring (IPSS, OABSS), but not all patients completed the follow-ups equally. <b>Results:</b> While patients with PBNO showed symptom improvement after surgery, the improvements were not always significant or clearly linked to the procedure itself. Interestingly, PBNO patients had shorter surgeries (27.2 vs. 60.5 minutes, <i>P</i><0.01), though it is unclear whether that impacted recovery. Despite reporting fewer complications, their satisfaction was lower (64.3% vs. 93.8%, <i>P</i>=0.09), perhaps due to reasons not directly assessed in the study. Repeated Measures ANOVA revealed a statistically significant improvement in IPSS scores over time in both groups: PBNO (F(2.1, 58.4)=16.8, <i>P</i><0.001) and BPH (F(2.4, 116.8)=21.3, <i>P</i><0.001). Similarly, OABSS scores showed a significant improvement over time for both PBNO (F(2.6, 74.0)=8.9, <i>P</i><0.001) and BPH (F(2.8, 134.2)=9.7, <i>P</i><0.001). <b>Conclusion:</b> HoLEP appears effective for PBNO, though it may not be the most suitable approach in all cases. Since PBNO differs from BPH, further studies might be needed, or perhaps not, depending on patient variability.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e19"},"PeriodicalIF":1.5,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12534764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-29eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.18
Pilar Rocio Blanco Flórez, Jennifer Orozco Páez
Introduction: Osteonecrosis causes the death of bone tissue due to insufficient blood flow, which disrupts the supply of oxygen and nutrients, compromising the structural integrity of the bone. The jaws are particularly vulnerable due to their high bone turnover and vascularization. This study aimed to present the complex case of a patient diagnosed with maxillary osteonecrosis associated with osteomyelitis, treated exclusively with laser therapy. Case Report: We present the case of a 62-year-old male patient with maxillary osteonecrosis associated with osteomyelitis, manifested by an oroantral fistula located in the upper jaw. The treatment consisted of various laser therapy modalities, starting with the surgical phase on hard tissue for the excision of the necrotic bone (Er,Cr:YSGG 2780 nm laser), followed by photodynamic therapy (650 nm diode laser) for wound disinfection and intravascular laser irradiation of blood (ILIB) therapy (880 nm diode laser) in each session. Conclusion: The combination of different laser wavelengths was effective for the treatment of osteonecrosis.
{"title":"Combination of Different Laser Wavelengths as a Treatment Strategy for Maxillary Osteonecrosis: A Case Report.","authors":"Pilar Rocio Blanco Flórez, Jennifer Orozco Páez","doi":"10.34172/jlms.2025.18","DOIUrl":"10.34172/jlms.2025.18","url":null,"abstract":"<p><p><b>Introduction:</b> Osteonecrosis causes the death of bone tissue due to insufficient blood flow, which disrupts the supply of oxygen and nutrients, compromising the structural integrity of the bone. The jaws are particularly vulnerable due to their high bone turnover and vascularization. This study aimed to present the complex case of a patient diagnosed with maxillary osteonecrosis associated with osteomyelitis, treated exclusively with laser therapy. <b>Case Report:</b> We present the case of a 62-year-old male patient with maxillary osteonecrosis associated with osteomyelitis, manifested by an oroantral fistula located in the upper jaw. The treatment consisted of various laser therapy modalities, starting with the surgical phase on hard tissue for the excision of the necrotic bone (Er,Cr:YSGG 2780 nm laser), followed by photodynamic therapy (650 nm diode laser) for wound disinfection and intravascular laser irradiation of blood (ILIB) therapy (880 nm diode laser) in each session. <b>Conclusion:</b> The combination of different laser wavelengths was effective for the treatment of osteonecrosis.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e18"},"PeriodicalIF":1.5,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.16
Alvand Naserghandi, Amir Reza Abedi, Mohammad Amin Tofighi Zavareh, Mohammad Javad Shahsavari, Mohammad Mehdi Shadravan, Soroush Mirzaei, Mohamad Amir Kakaee, Farzad Allameh
Introduction: Prostate cancer is the second most prevalent cancer in men and remains a major global health concern. Traditional treatment modalities such as radical prostatectomy (RP) and radiation therapy, while effective, often result in significant morbidity, including urinary incontinence and sexual dysfunction. Methods: A narrative review was conducted to synthesize current evidence on focal laser therapy for prostate cancer. A comprehensive literature search was performed across three major databases: PubMed, Scopus, and Web of Science. The search strategy employed the following Medical Subject Headings (MeSH) terms and keywords: ("Prostatic Neoplasms" [MeSH] OR "prostate cancer") AND ("Laser Therapy" [MeSH] OR "laser ablation" OR "focal therapy"). The search was limited to studies published between 2000 and 2024. Results: The initial search retrieved 1,444 articles. After a rigorous screening of titles, abstracts, and full-texts, 79 studies met the inclusion criteria and were incorporated into the review. The selected literature enables a comprehensive and critical evaluation of the current state of research on focal laser therapy in the management of prostate cancer. Conclusion: While focal laser therapies offer promising outcomes with fewer side effects, their long-term efficacy and survival benefits remain uncertain. High-quality studies with long-term follow-up are essential to better define their role in the prostate cancer treatment landscape and inform optimal patient selection.
简介:前列腺癌是男性中第二常见的癌症,仍然是一个主要的全球健康问题。传统的治疗方式,如根治性前列腺切除术(RP)和放射治疗,虽然有效,但往往导致严重的发病率,包括尿失禁和性功能障碍。方法:对前列腺癌局部激光治疗的文献进行综述。在三个主要数据库中进行了全面的文献检索:PubMed, Scopus和Web of Science。搜索策略采用以下医学主题标题(MeSH)术语和关键词:(“前列腺肿瘤”[MeSH]或“前列腺癌”)和(“激光治疗”[MeSH]或“激光消融”或“局灶治疗”)。这项研究仅限于2000年至2024年间发表的研究。结果:最初的搜索检索到1444篇文章。经过对标题、摘要和全文的严格筛选,有79项研究符合纳入标准,并被纳入本综述。所选的文献能够对前列腺癌病灶激光治疗的研究现状进行全面和批判性的评估。结论:虽然局部激光治疗具有良好的疗效和较少的副作用,但其长期疗效和生存效益仍不确定。高质量的长期随访研究对于更好地确定其在前列腺癌治疗中的作用和告知最佳患者选择至关重要。
{"title":"Prostate Cancer and the Rise of Focal Laser Therapies: A Narrative Review of Benefits and Limitations.","authors":"Alvand Naserghandi, Amir Reza Abedi, Mohammad Amin Tofighi Zavareh, Mohammad Javad Shahsavari, Mohammad Mehdi Shadravan, Soroush Mirzaei, Mohamad Amir Kakaee, Farzad Allameh","doi":"10.34172/jlms.2025.16","DOIUrl":"10.34172/jlms.2025.16","url":null,"abstract":"<p><p><b>Introduction:</b> Prostate cancer is the second most prevalent cancer in men and remains a major global health concern. Traditional treatment modalities such as radical prostatectomy (RP) and radiation therapy, while effective, often result in significant morbidity, including urinary incontinence and sexual dysfunction. <b>Methods:</b> A narrative review was conducted to synthesize current evidence on focal laser therapy for prostate cancer. A comprehensive literature search was performed across three major databases: PubMed, Scopus, and Web of Science. The search strategy employed the following Medical Subject Headings (MeSH) terms and keywords: (\"Prostatic Neoplasms\" [MeSH] OR \"prostate cancer\") AND (\"Laser Therapy\" [MeSH] OR \"laser ablation\" OR \"focal therapy\"). The search was limited to studies published between 2000 and 2024. <b>Results:</b> The initial search retrieved 1,444 articles. After a rigorous screening of titles, abstracts, and full-texts, 79 studies met the inclusion criteria and were incorporated into the review. The selected literature enables a comprehensive and critical evaluation of the current state of research on focal laser therapy in the management of prostate cancer. <b>Conclusion:</b> While focal laser therapies offer promising outcomes with fewer side effects, their long-term efficacy and survival benefits remain uncertain. High-quality studies with long-term follow-up are essential to better define their role in the prostate cancer treatment landscape and inform optimal patient selection.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e16"},"PeriodicalIF":1.5,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Spinal cord injury (SCI) is a debilitating condition characterized by primary mechanical damage followed by secondary injury processes, including inflammation and gliosis. These complex pathophysiological responses significantly hinder neuronal recovery and functional restoration. Emerging therapies, such as low-level laser therapy (LLLT), offer promising avenues for mitigating these secondary effects and promoting repair. This review aims to explore the pathophysiology of SCI, with a focus on inflammation and gliosis, and to evaluate the therapeutic potential of LLLT in improving outcomes after SCI. Methods: A comprehensive literature search was conducted across PubMed, Scopus, Cochrane Database, Google Scholar, and Web of Science databases to identify studies published from 2000 to 2024. Keywords included "spinal cord injury," "inflammation," "gliosis," and "low-level laser therapy." Articles were screened based on relevance, and data were extracted and synthesized to provide insights into the mechanisms and therapeutic applications. Results: Inflammation following SCI involves a cascade of cellular and molecular events that contribute to secondary damage. Gliosis, predominantly driven by astrocytes and microglia, forms a glial scar that impedes axonal regeneration. While these processes are initially protective, their prolonged activation exacerbates neural damage. LLLT has shown the potential to modulate these responses by reducing oxidative stress, promoting anti-inflammatory pathways, and enhancing neuroprotection. Preclinical studies demonstrate that LLLT improves functional recovery, reduces gliosis, and supports axonal regeneration, although standardized protocols and clinical validation remain challenges. Conclusion: The interplay between inflammation and gliosis significantly influences the outcomes of SCI. LLLT emerges as a promising therapeutic strategy by targeting these processes and promoting regeneration. Further research is needed to standardize LLLT protocols and validate its efficacy in clinical settings, paving the way for improved management of SCI.
简介:脊髓损伤(SCI)是一种衰弱性疾病,其特征是原发性机械损伤,继发性损伤过程,包括炎症和神经胶质瘤。这些复杂的病理生理反应严重阻碍了神经元的恢复和功能恢复。新兴疗法,如低水平激光治疗(LLLT),为减轻这些继发性影响和促进修复提供了有希望的途径。本综述旨在探讨脊髓损伤的病理生理学,重点关注炎症和神经胶质瘤,并评估LLLT在改善脊髓损伤后预后方面的治疗潜力。方法:对PubMed、Scopus、Cochrane数据库、谷歌Scholar和Web of Science数据库进行综合文献检索,确定2000年至2024年发表的研究。关键词包括“脊髓损伤”、“炎症”、“神经胶质瘤”和“低水平激光治疗”。文章根据相关性进行筛选,并提取和综合数据,以提供对机制和治疗应用的见解。结果:脊髓损伤后的炎症涉及一系列细胞和分子事件,导致继发性损伤。胶质瘤主要由星形胶质细胞和小胶质细胞驱动,形成阻碍轴突再生的胶质疤痕。虽然这些过程最初具有保护作用,但它们的长期激活会加剧神经损伤。LLLT已经显示出通过减少氧化应激、促进抗炎途径和增强神经保护来调节这些反应的潜力。临床前研究表明,LLLT可以改善功能恢复,减少神经胶质瘤,并支持轴突再生,尽管标准化的方案和临床验证仍然是挑战。结论:炎症与神经胶质瘤的相互作用对脊髓损伤的预后有显著影响。通过靶向这些过程并促进再生,LLLT成为一种很有前途的治疗策略。需要进一步的研究来规范LLLT方案并验证其在临床环境中的有效性,为改善SCI的管理铺平道路。
{"title":"Therapeutic Potential of Low-Level Laser Therapy in Controlling Inflammation and Damage-Associated Molecular Pattern Regulation in Spinal Cord Injury: A Systematic Review.","authors":"Hamid Reza Mosleh, Shahram Darabi, Hooman Kazemi Mirni, Sanaz Barisi, Zahra Mahdavirad, Hojjat-Allah Abbaszadeh, Leila Darabi","doi":"10.34172/jlms.2025.17","DOIUrl":"10.34172/jlms.2025.17","url":null,"abstract":"<p><p><b>Introduction:</b> Spinal cord injury (SCI) is a debilitating condition characterized by primary mechanical damage followed by secondary injury processes, including inflammation and gliosis. These complex pathophysiological responses significantly hinder neuronal recovery and functional restoration. Emerging therapies, such as low-level laser therapy (LLLT), offer promising avenues for mitigating these secondary effects and promoting repair. This review aims to explore the pathophysiology of SCI, with a focus on inflammation and gliosis, and to evaluate the therapeutic potential of LLLT in improving outcomes after SCI. <b>Methods:</b> A comprehensive literature search was conducted across PubMed, Scopus, Cochrane Database, Google Scholar, and Web of Science databases to identify studies published from 2000 to 2024. Keywords included \"spinal cord injury,\" \"inflammation,\" \"gliosis,\" and \"low-level laser therapy.\" Articles were screened based on relevance, and data were extracted and synthesized to provide insights into the mechanisms and therapeutic applications. <b>Results:</b> Inflammation following SCI involves a cascade of cellular and molecular events that contribute to secondary damage. Gliosis, predominantly driven by astrocytes and microglia, forms a glial scar that impedes axonal regeneration. While these processes are initially protective, their prolonged activation exacerbates neural damage. LLLT has shown the potential to modulate these responses by reducing oxidative stress, promoting anti-inflammatory pathways, and enhancing neuroprotection. Preclinical studies demonstrate that LLLT improves functional recovery, reduces gliosis, and supports axonal regeneration, although standardized protocols and clinical validation remain challenges. <b>Conclusion:</b> The interplay between inflammation and gliosis significantly influences the outcomes of SCI. LLLT emerges as a promising therapeutic strategy by targeting these processes and promoting regeneration. Further research is needed to standardize LLLT protocols and validate its efficacy in clinical settings, paving the way for improved management of SCI.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e17"},"PeriodicalIF":1.5,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-08eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.15
Fatemeh Dehghani, Roza Haghgoo, Mohammad Asnaashari, Hossein Dehghan
Introduction: Erosion is the loss of minerals by acids without the intervention of microorganisms. Complications caused by erosion make the use of therapeutic agents necessary. This study aims to survey the effects of the eggshell, the Er,Cr:YSGG laser, and their combination on the remineralization of erosive lesions caused by lemonade. Methods: The microhardness of 40 impacted third molar teeth was measured in this laboratory study. Then, the samples were subjected to an erosion challenge using a regular lemonade drink. After measuring microhardness, the samples were exposed to remineralizing materials: Er, Cr:YSG laser, eggshell, laser Er,Cr:YSGG, eggshell, and fluoride (positive control), and artificial saliva (negative control). Finally, data were analyzed via Kolmogorov-Smirnov, mixed-model analysis of variance (ANOVA), and LSD post hoc tests. Results: The microhardness of permanent third molar teeth, which was reduced after using lemonade, increased significantly after laser application compared to fluoride and artificial saliva. No significant difference was observed between the five experimental groups while there were statistically significant differences between the three stages of the study. Moreover, there was a significant interaction between the groups and stages (group * stage). The SMH of fluoride, artificial saliva, and laser+solution groups did not significantly change in the three stages of the study whilst the SMH of laser and solution groups significantly changed in the three stages. The SMH of the laser group had the most increasing trend (between erosive and treatment stages), followed by laser+solution and solution groups. However, the change in the laser+solution group was not statistically noticeable. Conclusion: Based on the results of this study, the Er,Cr:YSGG laser alone can be effective in the remineralization of erosive lesions caused by lemonade.
{"title":"Evaluation of Effects of Er,Cr:YSGG Laser, Eggshell Solution, and Their Combination on the Remineralization of Erosive Lesion Caused by Lemonade.","authors":"Fatemeh Dehghani, Roza Haghgoo, Mohammad Asnaashari, Hossein Dehghan","doi":"10.34172/jlms.2025.15","DOIUrl":"10.34172/jlms.2025.15","url":null,"abstract":"<p><p><b>Introduction:</b> Erosion is the loss of minerals by acids without the intervention of microorganisms. Complications caused by erosion make the use of therapeutic agents necessary. This study aims to survey the effects of the eggshell, the Er,Cr:YSGG laser, and their combination on the remineralization of erosive lesions caused by lemonade. <b>Methods:</b> The microhardness of 40 impacted third molar teeth was measured in this laboratory study. Then, the samples were subjected to an erosion challenge using a regular lemonade drink. After measuring microhardness, the samples were exposed to remineralizing materials: Er, Cr:YSG laser, eggshell, laser Er,Cr:YSGG, eggshell, and fluoride (positive control), and artificial saliva (negative control). Finally, data were analyzed via Kolmogorov-Smirnov, mixed-model analysis of variance (ANOVA), and LSD post hoc tests. <b>Results:</b> The microhardness of permanent third molar teeth, which was reduced after using lemonade, increased significantly after laser application compared to fluoride and artificial saliva. No significant difference was observed between the five experimental groups while there were statistically significant differences between the three stages of the study. Moreover, there was a significant interaction between the groups and stages (group * stage). The SMH of fluoride, artificial saliva, and laser+solution groups did not significantly change in the three stages of the study whilst the SMH of laser and solution groups significantly changed in the three stages. The SMH of the laser group had the most increasing trend (between erosive and treatment stages), followed by laser+solution and solution groups. However, the change in the laser+solution group was not statistically noticeable. <b>Conclusion:</b> Based on the results of this study, the Er,Cr:YSGG laser alone can be effective in the remineralization of erosive lesions caused by lemonade.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e15"},"PeriodicalIF":1.5,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-31eCollection Date: 2025-01-01DOI: 10.34172/jlms.2025.14
Carlos Eduardo Girasol, Luis Carlos Caseiro Filho, José Miguel Andrade Ferraz Moraes, Mateus Lelé Rinaldi, Marcelo Papoti, Rinaldo Roberto de Jesus Guirro
Introduction: Recent evidence suggests that the combination of exercise and photobiomodulation therapy (PBMT) enhances muscle performance, including improvements in strength, hypertrophy, and fatigue resistance. As muscle tissue changes after training, a dose progression over time may show additional effects. However, there needs to be more clarity regarding the optimal physical parameters for enhancing muscle performance. Thus, the aim was to evaluate the impact of strength training combined with PBMT at fixed or progressive doses on strength performance, metabolic activity, and clinical outcomes in healthy individuals. Methods: This was a double-blind, randomized clinical trial. Fifty-six male participants were randomly allocated into four groups: Sham, minimal dose (60 J), maximal dose (300 J), and incremental dose (60-300 J). Baseline assessments included body composition analysis and isokinetic dynamometry (peak torque and total work of the quadriceps femoris and hamstring muscles), followed by ten sessions of strength training combined with PBMT applied before each exercise session, which consisted of three sets of stiff and squats. PBMT irradiation was applied to the quadriceps and hamstrings. Training loads and psychophysiological responses were monitored throughout the intervention. Participants were reassessed at the end of the training period and followed up for a total duration of seven days. Results: No significant differences were observed between the groups in isokinetic strength parameters (P>0.05), although small to moderate effect sizes favored the Incremental and Maximal Dose groups. Similar patterns were found for psychophysiological responses and training loads across the groups. Conclusion: In the context of this research model, PBMT combined with strength training did not yield superior outcomes in muscle strength, psychophysiological, or metabolic parameters compared to the different dosing strategies evaluated.
{"title":"Impact of Photobiomodulation Therapy Dosing Strategies on Strength, Clinical Outcomes, and Metabolic Responses: A Blinded Randomized Clinical Trial.","authors":"Carlos Eduardo Girasol, Luis Carlos Caseiro Filho, José Miguel Andrade Ferraz Moraes, Mateus Lelé Rinaldi, Marcelo Papoti, Rinaldo Roberto de Jesus Guirro","doi":"10.34172/jlms.2025.14","DOIUrl":"10.34172/jlms.2025.14","url":null,"abstract":"<p><p><b>Introduction:</b> Recent evidence suggests that the combination of exercise and photobiomodulation therapy (PBMT) enhances muscle performance, including improvements in strength, hypertrophy, and fatigue resistance. As muscle tissue changes after training, a dose progression over time may show additional effects. However, there needs to be more clarity regarding the optimal physical parameters for enhancing muscle performance. Thus, the aim was to evaluate the impact of strength training combined with PBMT at fixed or progressive doses on strength performance, metabolic activity, and clinical outcomes in healthy individuals. <b>Methods:</b> This was a double-blind, randomized clinical trial. Fifty-six male participants were randomly allocated into four groups: Sham, minimal dose (60 J), maximal dose (300 J), and incremental dose (60-300 J). Baseline assessments included body composition analysis and isokinetic dynamometry (peak torque and total work of the quadriceps femoris and hamstring muscles), followed by ten sessions of strength training combined with PBMT applied before each exercise session, which consisted of three sets of stiff and squats. PBMT irradiation was applied to the quadriceps and hamstrings. Training loads and psychophysiological responses were monitored throughout the intervention. Participants were reassessed at the end of the training period and followed up for a total duration of seven days. <b>Results:</b> No significant differences were observed between the groups in isokinetic strength parameters (<i>P</i>>0.05), although small to moderate effect sizes favored the Incremental and Maximal Dose groups. Similar patterns were found for psychophysiological responses and training loads across the groups. <b>Conclusion:</b> In the context of this research model, PBMT combined with strength training did not yield superior outcomes in muscle strength, psychophysiological, or metabolic parameters compared to the different dosing strategies evaluated.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e14"},"PeriodicalIF":1.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The current study aims at evaluating the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration by comparing the clinical parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap (SPPF) alone and SPPF with the adjunctive use of LLLT. Methods: The current study is a randomized controlled clinical trial involving 64 patients/sites, 32 sites treated with SPPF - control group and 32 sites treated with SPPF and adjunctive use of LLLT (SPPF+LLLT) - test group. Clinical parameters such as probing pocket depth (PPD), clinical attachment level (CAL), position of gingival margin (PGM), radiographic intra-bony defect depth (R-IBD), full mouth plaque score (FMPS), and full mouth bleeding score (FMBS) were evaluated at baseline, 6 months, and one year post-surgery. Radiographic defect depths were assessed at baseline and one year post-surgery. The results were statistically analyzed. Results: There was a statistically significant reduction in the PPD, CAL, PGM, and radiographic defect depth in the test group at the 6 months and one year post-surgery when compared with the control group (P<0.05). In addition, the total number of sites with PPD more than 4 mm was reduced significantly in the test group when compared to the control group at 6 months and one year. Conclusion: The current study reports a significant improvement in PPD and radiographic intrabony defect fill in periodontitis patients treated with adjunctive LLLT supplementing SPPF. The article evaluates the adjunctive usage of LLLT in periodontal regeneration. The results reiterate the synergistic role of LLLT with periodontal surgical therapy for accelerated regenerative outcomes.
{"title":"Evaluation of LLLT Along With Minimally Invasive Flaps in Regeneration of Periodontal Intrabony Defects: A Randomized Controlled Clinical Trial.","authors":"Prakash Psg, Kavitha Sanjeev, Sangeetha Subramanian, Abirami Thanigaimalai, Devapriya Appukuttan","doi":"10.34172/jlms.2025.13","DOIUrl":"10.34172/jlms.2025.13","url":null,"abstract":"<p><p><b>Introduction:</b> The current study aims at evaluating the effectiveness of low level laser therapy (LLLT) in intra-bony defect regeneration by comparing the clinical parameters between periodontitis patients with intra-bony defects treated with simplified papilla preservation flap (SPPF) alone and SPPF with the adjunctive use of LLLT. <b>Methods:</b> The current study is a randomized controlled clinical trial involving 64 patients/sites, 32 sites treated with SPPF - control group and 32 sites treated with SPPF and adjunctive use of LLLT (SPPF+LLLT) - test group. Clinical parameters such as probing pocket depth (PPD), clinical attachment level (CAL), position of gingival margin (PGM), radiographic intra-bony defect depth (R-IBD), full mouth plaque score (FMPS), and full mouth bleeding score (FMBS) were evaluated at baseline, 6 months, and one year post-surgery. Radiographic defect depths were assessed at baseline and one year post-surgery. The results were statistically analyzed. <b>Results:</b> There was a statistically significant reduction in the PPD, CAL, PGM, and radiographic defect depth in the test group at the 6 months and one year post-surgery when compared with the control group (<i>P</i><0.05). In addition, the total number of sites with PPD more than 4 mm was reduced significantly in the test group when compared to the control group at 6 months and one year. <b>Conclusion:</b> The current study reports a significant improvement in PPD and radiographic intrabony defect fill in periodontitis patients treated with adjunctive LLLT supplementing SPPF. The article evaluates the adjunctive usage of LLLT in periodontal regeneration. The results reiterate the synergistic role of LLLT with periodontal surgical therapy for accelerated regenerative outcomes.</p>","PeriodicalId":16224,"journal":{"name":"Journal of lasers in medical sciences","volume":"16 ","pages":"e13"},"PeriodicalIF":1.5,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144957308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}